Pbx2 Inhibitors
Pbx2 inhibitors are a class of chemical compounds designed to modulate the activity of the Pre-B-cell leukemia transcription factor 2 (Pbx2), a critical homeobox transcription factor involved in regulating gene expression during development and differentiation. Pbx2 belongs to the TALE (Three Amino Acid Loop Extension) family of proteins and functions by forming heterodimeric or heterotrimeric complexes with other transcription factors, such as Hox proteins. These complexes bind to specific DNA sequences, controlling the transcription of genes essential for processes like embryogenesis, organ development, and cell fate determination. By inhibiting Pbx2, researchers aim to dissect its role in various biological pathways and understand the mechanisms underlying gene regulation.
The design of Pbx2 inhibitors focuses on disrupting the protein-protein interactions or DNA-binding capabilities of Pbx2. Chemically, these inhibitors may be small molecules, peptides, or other biologically active compounds that interact specifically with Pbx2's homeodomain or its interaction interfaces with partner proteins. By binding to these critical regions, the inhibitors prevent Pbx2 from forming functional complexes or accessing its target DNA sequences, thereby modulating gene expression patterns. Research into Pbx2 inhibitors involves techniques such as structure-based drug design, high-throughput screening, and computational modeling to identify and optimize compounds with high specificity and efficacy. Understanding the structural and functional aspects of Pbx2 and its inhibitors is essential for advancing knowledge in fields like developmental biology and gene regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a potent inhibitor of protein kinase C (PKC), which can indirectly inhibit Pbx2 by preventing the phosphorylation and subsequent activation of transcription factors that cooperate with Pbx2 in regulating gene expression. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Gö6976 is an inhibitor of PKC, specifically targeting the alpha and beta isoforms. By inhibiting PKC, the phosphorylation state and activity of transcription factors that interact with Pbx2 are altered, indirectly leading to the inhibition of Pbx2 function in transcriptional regulation. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
RO-31-8220 functions as a PKC inhibitor. It can indirectly inhibit Pbx2 by hindering the activation of PKC-dependent signaling pathways which are necessary for the transcriptional activity where Pbx2 is a co-regulator, thereby reducing Pbx2's functional participation in these pathways. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a selective inhibitor of PKC. This inhibition can decrease the phosphorylation-dependent regulation of transcription factors that are known to interact with Pbx2, thereby indirectly inhibiting Pbx2's role in transcriptional regulation networks. | ||||||
Sotrastaurin | 425637-18-9 | sc-474229 sc-474229A | 5 mg 10 mg | $300.00 $540.00 | ||
Sotrastaurin is an inhibitor of PKC. It can inhibit Pbx2 indirectly by targeting the PKC-mediated signaling pathways which modulate the activity of transcription factors that work in conjunction with Pbx2, thus affecting Pbx2's regulatory functions. | ||||||
Ruboxistaurin | 169939-94-0 | sc-507364 | 25 mg | $1080.00 | ||
Ruboxistaurin, a selective inhibitor of PKC beta isoform, can indirectly inhibit Pbx2 by impairing the activation of PKC-beta-dependent transcription factors that collaborate with Pbx2 in gene expression regulation. | ||||||
Enzastaurin | 170364-57-5 | sc-364488 sc-364488A sc-364488B | 10 mg 50 mg 200 mg | $259.00 $612.00 $1721.00 | 3 | |
Enzastaurin is a PKC beta inhibitor. By inhibiting PKC beta, it can indirectly inhibit Pbx2 by reducing the activation of transcriptional pathways in which Pbx2 is involved, thus diminishing Pbx2's functional role in these pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, which includes inhibition of PKC. This broad inhibition can lead to a reduction in PKC-mediated phosphorylation events that are crucial for the co-regulatory function of Pbx2 in transcriptional regulation, thus indirectly leading to the functional inhibition of Pbx2. | ||||||
Hispidin | 555-55-5 | sc-203998 | 5 mg | $416.00 | ||
Hispidin is a PKC inhibitor. It can functionally inhibit Pbx2 indirectly by preventing PKC-mediated phosphorylation processes that are essential for the activation of transcriptional partners of Pbx2, ultimately influencing Pbx2's role in gene regulation. | ||||||
Balanol | 63590-19-2 | sc-503251 | 10 mg | $13500.00 | ||
Balanol is an inhibitor of PKC. It can lead to the functional inhibition of Pbx2 indirectly by hampering the PKC-dependent phosphorylation of transcription factors that synergize with Pbx2, thereby affecting the transcriptional control exerted by Pbx2. | ||||||